Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemotherapy and Pamidronate in Newly Diagnosed Osteosarcoma
NCT00586846Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Jul 2003
- Primary completion
- Feb 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of pamidronate in osteosarcoma (OS), sponsored by Memorial Sloan Kettering Cancer Center. Primary endpoint: Radiographic Response at 2 years. Started Jul 2003; status: completed.
02
Drugs
pamidronate
03
Conditions
osteosarcoma (OS)
Beyond the preview
Go deeper on NCT00586846.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00586846.